BioXcel Therapeutics Stock (NASDAQ: BTAI) stock price, news, charts, stock research, profile.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Curis (NASDAQ:CRIS), Bolt Biotherapeutics (NASDAQ:BOLT), Geovax Labs (NASDAQ:GOVX) and Palatin Techs (AMEX:PTN).
BioXcel Therapeutics has a consensus price target of $7.14.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $0.665 last updated November 13, 2024 at 5:19 AM EST.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q3 earnings are confirmed for Thursday, November 14, 2024.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.